Rutgers Health researchers have discovered that networks of misplaced immune cells drive an aggressive lung disease, ...
Septerna Provides Corporate Overview and Reports Fourth Quarter and Full Year 2024 Financial Results
Corporate Updates: In January 2025, Septerna appointed Gil Labrucherie, CFA, J.D., as chief financial officer. Mr. Labrucherie is a seasoned biopharma executive with more than 25 years of senior ...
The mammalian immune system is an evolutionary wonder. It's capable of recognizing and destroying cancer cells, and it can ...
Scientists used advanced data analysis and machine learning to identify the viral proteins that may trigger autoimmune disorders such as type 1 diabetes and rheumatoid arthritis.
Americans dying avoidable deaths, reforming the kidney transplant system, a new CDC director nominee, and more in today's ...
Type I allergy, an IgE antibody triggered hypersensitivity disease, represents a common public health problem affecting about one third of the world´s population. Upon exposure to allergens, IgE ...
In a case report published in the World Journal of Oncology, an elderly female patient was diagnosed with mast cell leukemia (MCL), with imaging showing extensive osteoblastic metastatic lesions. MCL ...
Discover 8 ways mast cell activation syndrome causes widespread symptoms from digestive issues to brain fog, often mistaken ...
It also recognizes and removes dead and faulty cells. In autoimmune diseases and allergies, the immune system mistakenly perceives healthy tissue as unhealthy and launches an unnecessary attack ...
Adalja is an infectious disease physician and a senior scholar at the Center for Health Security at the Bloomberg School of Public Health at Johns Hopkins University. Vergara Cid is an immigration ...
At the recent AAAAI/WAO meeting, Blueprint Medicines Corp. presented the in vitro and in vivo characterization of BLU-808, a selective inhibitor of wild-type KIT, a transmembrane receptor tyrosine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results